SLC5A2 and type 2 diabetes mellitus: A prospective observational study involving 377 participants discovered that postoperative restenosis rates differed among patients with type 2 diabetes and acute myocardial infarction (AMI) based on whether they were prescribed oral sodium/glucose cotransporter 2 (SGLT2) inhibitors [46].